Published in Med Decis Making on February 11, 2008
Scaling CRC Screening Through Outreach, Referral, and Engagement (SCORE) (SCORE) | NCT04406714
Socioeconomic and racial patterns of colorectal cancer screening among Medicare enrollees in 2000 to 2005. Cancer Epidemiol Biomarkers Prev (2009) 2.10
Economic burden of cancer in the United States: estimates, projections, and future research. Cancer Epidemiol Biomarkers Prev (2011) 1.82
Challenges and possible solutions to colorectal cancer screening for the underserved. J Natl Cancer Inst (2014) 1.61
Colorectal cancer screening for average-risk North Americans: an economic evaluation. PLoS Med (2010) 1.51
Primary care, economic barriers to health care, and use of colorectal cancer screening tests among Medicare enrollees over time. Ann Fam Med (2010) 1.47
Rapid colonoscopy preparation using bolus lukewarm saline combined with sequential posture changes: a randomized controlled trial. Dig Dis Sci (2013) 1.39
Costs and cost-effectiveness of full implementation of a biennial faecal occult blood test screening program for bowel cancer in Australia. Med J Aust (2011) 1.18
Conjoint analysis versus rating and ranking for values elicitation and clarification in colorectal cancer screening. J Gen Intern Med (2011) 1.17
Screening for colorectal cancer: possible improvements by risk assessment evaluation? Scand J Gastroenterol (2011) 0.99
Patient time requirements for anticoagulation therapy with warfarin. Med Decis Making (2009) 0.97
Carbon dioxide for gut distension during digestive endoscopy: technique and practice survey. World J Gastroenterol (2009) 0.94
Estimating the cost of no-shows and evaluating the effects of mitigation strategies. Med Decis Making (2013) 0.89
Annual patient time costs associated with medical care among cancer survivors in the United States. Med Care (2014) 0.86
Willingness-to-pay to avoid the time spent and discomfort associated with screening colonoscopy. Health Econ (2010) 0.86
Effectiveness of a patient- and practice-level colorectal cancer screening intervention in health plan members: design and baseline findings of the CHOICE trial. Cancer (2010) 0.85
Missed work related to mid-week screening colonoscopy. Dig Dis Sci (2011) 0.84
Farm Fresh Foods for Healthy Kids (F3HK): An innovative community supported agriculture intervention to prevent childhood obesity in low-income families and strengthen local agricultural economies. BMC Public Health (2017) 0.75
A game-theoretic framework for estimating a health purchaser's willingness-to-pay for health and for expansion. Health Care Manag Sci (2010) 0.75
Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med (2005) 15.46
A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med (2003) 9.18
Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA (2007) 7.93
Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology (2012) 7.15
Understanding cancer treatment and outcomes: the Cancer Care Outcomes Research and Surveillance Consortium. J Clin Oncol (2004) 7.02
Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med (2002) 5.65
Association of numeracy and diabetes control. Ann Intern Med (2008) 5.08
Is this patient clinically depressed? JAMA (2002) 5.03
Colorectal cancer in patients under close colonoscopic surveillance. Gastroenterology (2005) 4.31
Influence of patient literacy on the effectiveness of a primary care-based diabetes disease management program. JAMA (2004) 4.16
Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults. Gastroenterology (2008) 3.79
Using the coronary artery calcium score to predict coronary heart disease events: a systematic review and meta-analysis. Arch Intern Med (2004) 3.64
Vitamin D, calcium supplementation, and colorectal adenomas: results of a randomized trial. J Natl Cancer Inst (2003) 3.44
Clinical practice. Screening for colorectal cancer. N Engl J Med (2002) 3.43
A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas. Gastroenterology (2006) 3.35
Constipation and a low-fiber diet are not associated with diverticulosis. Clin Gastroenterol Hepatol (2013) 3.31
Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials. J Natl Cancer Inst (2009) 3.15
Identifying depression in primary care: a literature synthesis of case-finding instruments. Gen Hosp Psychiatry (2002) 3.15
A high-fiber diet does not protect against asymptomatic diverticulosis. Gastroenterology (2011) 3.03
Variability in diagnostic criteria for eosinophilic esophagitis: a systematic review. Am J Gastroenterol (2007) 2.94
The burden of gastrointestinal and liver diseases, 2006. Am J Gastroenterol (2006) 2.93
A Trial of Calcium and Vitamin D for the Prevention of Colorectal Adenomas. N Engl J Med (2015) 2.88
Cardiovascular events associated with rofecoxib: final analysis of the APPROVe trial. Lancet (2008) 2.83
Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol (2010) 2.80
A population-based cohort study comparing laparoscopic cholecystectomy and open cholecystectomy. Am J Gastroenterol (2002) 2.75
Molecular characterization of mucosal adherent bacteria and associations with colorectal adenomas. Gut Microbes (2010) 2.70
Folic acid and risk of prostate cancer: results from a randomized clinical trial. J Natl Cancer Inst (2009) 2.64
A germline variant in the TP53 polyadenylation signal confers cancer susceptibility. Nat Genet (2011) 2.43
Development and validation of the Diabetes Numeracy Test (DNT). BMC Health Serv Res (2008) 2.42
RNA expression analysis of formalin-fixed paraffin-embedded tumors. Lab Invest (2007) 2.25
How to decide whether a clinical practice guideline is trustworthy. JAMA (2013) 2.24
Development of an internet-based cohort of patients with inflammatory bowel diseases (CCFA Partners): methodology and initial results. Inflamm Bowel Dis (2012) 2.23
Framingham-based tools to calculate the global risk of coronary heart disease: a systematic review of tools for clinicians. J Gen Intern Med (2003) 2.22
KRAS/BRAF mutation status and ERK1/2 activation as biomarkers for MEK1/2 inhibitor therapy in colorectal cancer. Mol Cancer Ther (2009) 2.22
Digestive and liver diseases statistics, 2004. Gastroenterology (2004) 2.14
A causal association between isotretinoin and inflammatory bowel disease has yet to be established. Am J Gastroenterol (2009) 2.14
Circulating levels of inflammatory cytokines and risk of colorectal adenomas. Cancer Res (2008) 2.13
Isotretinoin use and the risk of inflammatory bowel disease: a case-control study. Am J Gastroenterol (2010) 2.10
National Institutes of Health state-of-the-science conference statement: prevention of fecal and urinary incontinence in adults. Ann Intern Med (2008) 2.10
Associations of total energy and macronutrients with colon cancer risk in African Americans and Whites: results from the North Carolina colon cancer study. Am J Epidemiol (2003) 2.06
Data sources for measuring colorectal endoscopy use among Medicare enrollees. Cancer Epidemiol Biomarkers Prev (2007) 2.02
The relationship between literacy and glycemic control in a diabetes disease-management program. Diabetes Educ (2004) 2.02
Fusobacterium is associated with colorectal adenomas. PLoS One (2013) 1.99
The Spoken Knowledge in Low Literacy in Diabetes scale: a diabetes knowledge scale for vulnerable patients. Diabetes Educ (2005) 1.97
Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease. Gastroenterology (2012) 1.97
Patient-reported outcomes of breast reconstruction after mastectomy: a systematic review. J Am Coll Surg (2009) 1.94
New American Cancer Society process for creating trustworthy cancer screening guidelines. JAMA (2011) 1.88
Addressing literacy and numeracy to improve diabetes care: two randomized controlled trials. Diabetes Care (2009) 1.88
Sleep disturbance and risk of active disease in patients with Crohn's disease and ulcerative colitis. Clin Gastroenterol Hepatol (2013) 1.83
Association between hemochromatosis (HFE) gene mutation carrier status and the risk of colon cancer. J Natl Cancer Inst (2003) 1.80
Drug treatment of hyperlipidemia in women. JAMA (2004) 1.76
Patient time requirements for screening colonoscopy. Am J Gastroenterol (2007) 1.74
Prolonged effect of calcium supplementation on risk of colorectal adenomas in a randomized trial. J Natl Cancer Inst (2007) 1.73
Editorial: colonoscopy and colorectal cancer mortality: strong beliefs or strong facts? Am J Gastroenterol (2010) 1.71
Characteristics and survival of interval and sporadic colorectal cancer patients: a nationwide population-based cohort study. Am J Gastroenterol (2013) 1.71
Suboptimal rates of cervical testing among women with inflammatory bowel disease. Clin Gastroenterol Hepatol (2008) 1.71
Tacrolimus for the treatment of fistulas in patients with Crohn's disease: a randomized, placebo-controlled trial. Gastroenterology (2003) 1.70
Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study. Gut (2011) 1.70
Loss of activin receptor type 2 protein expression in microsatellite unstable colon cancers. Gastroenterology (2004) 1.70
Determinants of medical system delay in the diagnosis of colorectal cancer within the Veteran Affairs Health System. Dig Dis Sci (2010) 1.68
Effect of calcium supplementation on the risk of large bowel polyps. J Natl Cancer Inst (2004) 1.67
Reduced polyp detection as endoscopy shift progresses: experience with screening colonoscopy at a tertiary-care hospital. J Clin Gastroenterol (2011) 1.66
Using the coronary artery calcium score to guide statin therapy: a cost-effectiveness analysis. Circ Cardiovasc Qual Outcomes (2014) 1.65
Relationship between literacy, knowledge, self-care behaviors, and heart failure-related quality of life among patients with heart failure. J Gen Intern Med (2011) 1.64
Increased rectal microbial richness is associated with the presence of colorectal adenomas in humans. ISME J (2012) 1.62
Development and pilot testing of a disease management program for low literacy patients with heart failure. Patient Educ Couns (2004) 1.58
Comparing 3 values clarification methods for colorectal cancer screening decision-making: a randomized trial in the US and Australia. J Gen Intern Med (2013) 1.57
Insulin resistance, apoptosis, and colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev (2005) 1.52
Donor morbidity associated with right lobectomy for living donor liver transplantation to adult recipients: a systematic review. Liver Transpl (2002) 1.52
The impact of a novel computer-based decision aid on shared decision making for colorectal cancer screening: a randomized trial. Med Decis Making (2010) 1.51
Development and initial testing of a computer-based patient decision aid to promote colorectal cancer screening for primary care practice. BMC Med Inform Decis Mak (2005) 1.50
Recognition and treatment of irritable bowel syndrome among women with chronic pelvic pain. Am J Obstet Gynecol (2005) 1.49
A single-item self-report medication adherence question predicts hospitalisation and death in patients with heart failure. J Clin Nurs (2013) 1.48
Risk factors for advanced colorectal adenomas: a pooled analysis. Cancer Epidemiol Biomarkers Prev (2002) 1.48
Relationship of EMAST and microsatellite instability among patients with rectal cancer. J Gastrointest Surg (2010) 1.48
Role of Nonsteroidal Anti-Inflammatory Drugs in Exacerbations of Inflammatory Bowel Disease. J Clin Gastroenterol (2016) 1.47
Diet, lifestyle, and genomic instability in the North Carolina Colon Cancer Study. Cancer Epidemiol Biomarkers Prev (2005) 1.45
Longitudinal changes in lifestyle behaviors and health status in colon cancer survivors. Cancer Epidemiol Biomarkers Prev (2004) 1.45
Numeracy and the medical student's ability to interpret data. Eff Clin Pract (2002) 1.44
Interpreting Hemoglobin A1C in Combination With Conventional Risk Factors for Prediction of Cardiovascular Risk. Circ Cardiovasc Qual Outcomes (2015) 1.40
Research recruitment through US central cancer registries: balancing privacy and scientific issues. Am J Public Health (2006) 1.37
Identifying specific chemotherapeutic agents in Medicare data: a validation study. Med Care (2013) 1.36
Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association. Circulation (2015) 1.33
Utilization of healthcare resources by U.S. children and adults with inflammatory bowel disease. Inflamm Bowel Dis (2011) 1.33
Social ties and colorectal cancer screening among Blacks and Whites in North Carolina. Cancer Epidemiol Biomarkers Prev (2005) 1.31
Genetic heterogeneity in colorectal cancer associations between African and European americans. Gastroenterology (2010) 1.31
Associations of micronutrients with colon cancer risk in African Americans and whites: results from the North Carolina Colon Cancer Study. Cancer Epidemiol Biomarkers Prev (2003) 1.29
Dietary patterns and self-reported associations of diet with symptoms of inflammatory bowel disease. Dig Dis Sci (2012) 1.27
Screening for high blood pressure: a review of the evidence for the U.S. Preventive Services Task Force. Am J Prev Med (2003) 1.24
Are patient decision aids the best way to improve clinical decision making? Report of the IPDAS Symposium. Med Decis Making (2007) 1.24
Evaluation of claims, medical records, and self-report for measuring fecal occult blood testing among medicare enrollees in fee for service. Cancer Epidemiol Biomarkers Prev (2008) 1.24
Influence of target gene mutations on survival, stage and histology in sporadic microsatellite unstable colon cancers. Int J Cancer (2006) 1.22
Clarifying values: an updated review. BMC Med Inform Decis Mak (2013) 1.22
Impact of the 2008-2009 economic recession on screening colonoscopy utilization among the insured. Clin Gastroenterol Hepatol (2011) 1.21
Peptic ulcer and bleeding events associated with rofecoxib in a 3-year colorectal adenoma chemoprevention trial. Gastroenterology (2006) 1.21
Measures used in studies of informed decision making about cancer screening: a systematic review. Ann Behav Med (2006) 1.20
Nonsteroidal anti-inflammatory drugs, apoptosis, and colorectal adenomas. Gastroenterology (2002) 1.20